324 participants
The REbif® vs Glatiramer Acetate in Relapsing Multiple Sclerosis Pharmacogenetics Trial
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2014-03-10
- Start Date:
- 2010-02-28
- Completion:
- 2010-11-30
Conditions
- Relapsing Multiple Sclerosis
Interventions
- OTHER